<DOC>
	<DOCNO>NCT01530269</DOCNO>
	<brief_summary>Positron emission tomography use carbon-11 acetate ( AC-PET ) may help find local distant metastasis prostate cancer . This clinical trial study image test may help influence choice extent initial treatment , subsequent treatment .</brief_summary>
	<brief_title>C11-Sodium Acetate PET/CT Imaging Metastatic Disease Intermediate-to-high Risk Prostate Adenocarcinoma</brief_title>
	<detailed_description>OBJECTIVES : - Determine role positron emission tomography use carbon-11 acetate ( AC-PET ) initial subsequent management patient prostate cancer intermediate high risk recurrence initial curative therapy . - Compare value AC-PET predict recurrence prostate cancer conventional approach ( e.g. , pre-operative clinical staging , prostate-specific antigen , Gleason score , prostate lymph node histology ) patient .</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Male patient studied prostate cancer : Diagnosed prostate adenocarcinoma Has complete conventional staging examination , include histologic evaluation Gleason score , CT scan abdomen pelvis , wholebody bone scintigraphy Candidate curative prostatectomy OR curative radiotherapy OR stag lymphadenectomy prior surgery Deemed intermediate high risk recurrence metastatic disease initial curative treatment , define one following : Gleason score &gt; = 7 PSA &gt; = 10 Gleason score &lt; 7 PSA &lt; 10 ng/mL positive surgical margin , biopsy proven suspect regional nodal involvement conventional image show limited metastatic disease may amenable directed radiotherapy Rising nonresponding PSA &lt; 18 year old claustrophobic patient</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>intermediate</keyword>
	<keyword>high</keyword>
	<keyword>risk</keyword>
	<keyword>radiation</keyword>
	<keyword>therapy</keyword>
	<keyword>planning</keyword>
	<keyword>surgical</keyword>
	<keyword>immunotherapy</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>hormone</keyword>
</DOC>